These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 8981755)

  • 21. Piperazinyl-glutamate-pyridines as potent orally bioavailable P2Y12 antagonists for inhibition of platelet aggregation.
    Parlow JJ; Burney MW; Case BL; Girard TJ; Hall KA; Hiebsch RR; Huff RM; Lachance RM; Mischke DA; Rapp SR; Woerndle RS; Ennis MD
    Bioorg Med Chem Lett; 2009 Aug; 19(16):4657-63. PubMed ID: 19604694
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [2-Arylidene 3,4-dihydro-1 (2H)-naphthalenones with potential platelet anti-aggregating activity: synthesis and structural and pharmacologic study].
    Varache-Beranger M; Nuhrich A; Devaux G; H'Naifi A; Carpy A
    Farmaco Sci; 1986 Feb; 41(2):156-67. PubMed ID: 3084294
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Synthesis and anti-platelet evaluation of 2-benzoylaminobenzoate analogs.
    Hsieh PW; Chiang SZ; Wu CC; Lo YC; Shih YT; Wu YC
    Bioorg Med Chem; 2008 May; 16(10):5803-14. PubMed ID: 18407506
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Losartan does not influence the blood platelet aggregation in normotensive rats.
    Chabielska E; Pawlak R; Buczko W
    Acta Physiol Hung; 1996; 84(3):271-2. PubMed ID: 9219602
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comparison of antiplatelet effects of two nitric oxide-donating agents, FR146801 and FK409.
    Hirasawa Y; Kato Y; Fukuyama S; Ohno M; Nishino S; Kato M; Kita Y
    Thromb Haemost; 1998 Mar; 79(3):620-4. PubMed ID: 9531052
    [TBL] [Abstract][Full Text] [Related]  

  • 26. New class of potent antinociceptive and antiplatelet 10H-phenothiazine-1-acylhydrazone derivatives.
    Silva GA; Costa LM; Brito FC; Miranda AL; Barreiro EJ; Fraga CA
    Bioorg Med Chem; 2004 Jun; 12(12):3149-58. PubMed ID: 15158783
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Human platelet aggregation inhibitors from thyme (Thymus vulgaris L.).
    Okazaki K; Kawazoe K; Takaishi Y
    Phytother Res; 2002 Jun; 16(4):398-9. PubMed ID: 12112303
    [TBL] [Abstract][Full Text] [Related]  

  • 28. SR 121787, a new orally active fibrinogen receptor antagonist.
    Savi P; Badorc A; Lalé A; Bordes MF; Bornia J; Labouret C; Bernat A; de Cointet P; Hoffmann P; Maffrand JP; Herbert JM
    Thromb Haemost; 1998 Sep; 80(3):469-76. PubMed ID: 9759629
    [TBL] [Abstract][Full Text] [Related]  

  • 29. 2-Substituted 4-, 5-, and 6-[(1E)-3-oxo-3-phenylprop-1-en-1-yl]pyridazin-3(2H)-ones and 2-substituted 4,5-bis[(1E)-3-oxo-3-phenylprop-1-en-1-yl]pyridazin-3(2H)-ones as potent platelet aggregation inhibitors: design, synthesis, and SAR studies.
    Meyers C; Yáñez M; Elmaatougi A; Verhelst T; Coelho A; Fraiz N; Lemière GL; García-Mera X; Laguna R; Cano E; Maes BU; Sotelo E
    Bioorg Med Chem Lett; 2008 Jan; 18(2):793-7. PubMed ID: 18053717
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Novel arylpyrazino[2,3-c][1,2,6]thiadiazine 2,2-dioxides as inhibitors of platelet aggregation. 1. Synthesis and pharmacological evaluation.
    Campillo N; García C; Goya P; Páez JA; Carrasco E; Grau M
    J Med Chem; 1999 May; 42(10):1698-704. PubMed ID: 10346922
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Synthesis and analgesic profile of conformationally constrained N-acylhydrazone analogues: discovery of novel N-arylideneamino quinazolin-4(3H)-one compounds derived from natural safrole.
    Maia RC; Silva LL; Mazzeu EF; Fumian MM; de Rezende CM; Doriguetto AC; Corrêa RS; Miranda AL; Barreiro EJ; Fraga CA
    Bioorg Med Chem; 2009 Sep; 17(18):6517-25. PubMed ID: 19699644
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pyridazines part 41: synthesis, antiplatelet activity and SAR of 2,4,6-substituted 5-(3-oxo-3-phenylprop-1-en-1-yl)- or 5-(3-phenylprop-2-enoyl)pyridazin-3(2H)-ones.
    Crespo A; Meyers C; Coelho A; Yáñez M; Fraiz N; Sotelo E; Maes BU; Laguna R; Cano E; Lemière GL; Raviña E
    Bioorg Med Chem Lett; 2006 Feb; 16(4):1080-3. PubMed ID: 16290144
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Mechanisms of antiplatelet activity of PC-09, a newly synthesized pyridazinone derivative.
    Cherng SC; Huang WH; Shiau CY; Lee AR; Chou TC
    Eur J Pharmacol; 2006 Feb; 532(1-2):32-7. PubMed ID: 16457809
    [TBL] [Abstract][Full Text] [Related]  

  • 34. New orally active non-peptide fibrinogen receptor (GpIIb-IIIa) antagonists: identification of ethyl 3-[N-[4-[4-[amino[(ethoxycarbonyl) imino]methyl]phenyl]-1,3-thiazol-2-yl]-N-[1-[(ethoxycarbonyl)methyl]pip erid -4-yl]amino]propionate (SR 121787) as a potent and long-acting antithrombotic agent.
    Badorc A; Bordes MF; de Cointet P; Savi P; Bernat A; Lalé A; Petitou M; Maffrand JP; Herbert JM
    J Med Chem; 1997 Oct; 40(21):3393-401. PubMed ID: 9341914
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Design and synthesis of novel biologically active thrombin receptor non-peptide mimetics based on the pharmacophoric cluster Phe/Arg/NH2 of the Ser42-Phe-Leu-Leu-Arg46 motif sequence: platelet aggregation and relaxant activities.
    Alexopoulos K; Fatseas P; Melissari E; Vlahakos D; Roumelioti P; Mavromoustakos T; Mihailescu S; Paredes-Carbajal MC; Mascher D; Matsoukas J
    J Med Chem; 2004 Jun; 47(13):3338-52. PubMed ID: 15189031
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Studies on quinazolines and 1,2,4-benzothiadiazine 1,1-dioxides. 8.1, 2 synthesis and pharmacological evaluation of tricyclic fused quinazolines and 1,2,4-benzothiadiazine 1,1-dioxides as potential alpha1-adrenoceptor antagonists.
    Chern JW; Tao PL; Wang KC; Gutcait A; Liu SW; Yen MH; Chien SL; Rong JK
    J Med Chem; 1998 Aug; 41(17):3128-41. PubMed ID: 9703460
    [TBL] [Abstract][Full Text] [Related]  

  • 37. 1- and 2-substituted naphthalenes: a new class of potential hypotensive agents.
    Tandon VK; Singh KA; Goswamy GK
    Bioorg Med Chem Lett; 2004 Jun; 14(11):2797-800. PubMed ID: 15125935
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Synthesis, antileukemic and antiplatelet activities of 2,3-diaryl-6,7-dihydro-5H-1,4-diazepines.
    Ramajayam R; Giridhar R; Yadav MR; Balaraman R; Djaballah H; Shum D; Radu C
    Eur J Med Chem; 2008 Sep; 43(9):2004-10. PubMed ID: 18191304
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Design, synthesis and pharmacological evaluation of new 1-[3-(4-arylpiperazin-1-yl)-2-hydroxy-propyl]-3,3-diphenylpyrrolidin-2-one derivatives with antiarrhythmic, antihypertensive, and alpha-adrenolytic activity.
    Kulig K; Sapa J; Nowaczyk A; Filipek B; Malawska B
    Eur J Med Chem; 2009 Oct; 44(10):3994-4003. PubMed ID: 19447527
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Feroniellin B, a new highly potent human platelet aggregation inhibitor from Feroniella lucida.
    Phuwapraisirisan P; Surapinit S; Jeenapongsa R; Tip-pyang S; Kokpol U
    Phytother Res; 2007 May; 21(5):485-7. PubMed ID: 17245685
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.